Cargando…

The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey

Purpose: Antimicrobial resistance among microorganisms is a global concern. In 2003, a nationwide antibiotic restriction program (NARP) was released in Turkey. In this study we evaluated the effect of NARP on antibiotic consumption, antimicrobial resistance, and cost. Materials and Methods: The data...

Descripción completa

Detalles Bibliográficos
Autores principales: Altunsoy, Adalet, Aypak, Cenk, Azap, Alpay, Ergönül, Önder, Balık, İsmail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107466/
https://www.ncbi.nlm.nih.gov/pubmed/21647326
_version_ 1782205226049077248
author Altunsoy, Adalet
Aypak, Cenk
Azap, Alpay
Ergönül, Önder
Balık, İsmail
author_facet Altunsoy, Adalet
Aypak, Cenk
Azap, Alpay
Ergönül, Önder
Balık, İsmail
author_sort Altunsoy, Adalet
collection PubMed
description Purpose: Antimicrobial resistance among microorganisms is a global concern. In 2003, a nationwide antibiotic restriction program (NARP) was released in Turkey. In this study we evaluated the effect of NARP on antibiotic consumption, antimicrobial resistance, and cost. Materials and Methods: The data obtained from all of the four university hospitals, and one referral tertiary-care educational state hospital in Ankara. Antimicrobial resistance profiles of 14,233 selected microorganisms all grown in blood cultures and antibiotic consumption from 2001 to 2005 were analyzed retrospectively. Results: A negative correlation was observed between the ceftriaxone consumption and the prevalence of ceftriaxone resistant E.coli and Klebsiella spp. (rho:-0.395, p:0.332 and rho:-0.627, p:0.037, respectively). The decreased usage of carbapenems was correlated with decreased carbapenems-resistant Pseudomonas spp. and Acinetobacter spp (rho:0.155, p:0.712 and rho:0.180, p:0.668, respectively for imipenem). Methicillin resistance rates of S.aureus were decreased from 44% to 41%. After two years of NARP 5,389,155.82 USD saving occurred. Conclusion: NARP is effective in lowering the costs and antibiotic resistance.
format Online
Article
Text
id pubmed-3107466
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-31074662011-06-06 The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey Altunsoy, Adalet Aypak, Cenk Azap, Alpay Ergönül, Önder Balık, İsmail Int J Med Sci Research Paper Purpose: Antimicrobial resistance among microorganisms is a global concern. In 2003, a nationwide antibiotic restriction program (NARP) was released in Turkey. In this study we evaluated the effect of NARP on antibiotic consumption, antimicrobial resistance, and cost. Materials and Methods: The data obtained from all of the four university hospitals, and one referral tertiary-care educational state hospital in Ankara. Antimicrobial resistance profiles of 14,233 selected microorganisms all grown in blood cultures and antibiotic consumption from 2001 to 2005 were analyzed retrospectively. Results: A negative correlation was observed between the ceftriaxone consumption and the prevalence of ceftriaxone resistant E.coli and Klebsiella spp. (rho:-0.395, p:0.332 and rho:-0.627, p:0.037, respectively). The decreased usage of carbapenems was correlated with decreased carbapenems-resistant Pseudomonas spp. and Acinetobacter spp (rho:0.155, p:0.712 and rho:0.180, p:0.668, respectively for imipenem). Methicillin resistance rates of S.aureus were decreased from 44% to 41%. After two years of NARP 5,389,155.82 USD saving occurred. Conclusion: NARP is effective in lowering the costs and antibiotic resistance. Ivyspring International Publisher 2011-05-24 /pmc/articles/PMC3107466/ /pubmed/21647326 Text en © Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited.
spellingShingle Research Paper
Altunsoy, Adalet
Aypak, Cenk
Azap, Alpay
Ergönül, Önder
Balık, İsmail
The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey
title The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey
title_full The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey
title_fullStr The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey
title_full_unstemmed The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey
title_short The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey
title_sort impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in turkey
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107466/
https://www.ncbi.nlm.nih.gov/pubmed/21647326
work_keys_str_mv AT altunsoyadalet theimpactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey
AT aypakcenk theimpactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey
AT azapalpay theimpactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey
AT ergonulonder theimpactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey
AT balıkismail theimpactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey
AT altunsoyadalet impactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey
AT aypakcenk impactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey
AT azapalpay impactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey
AT ergonulonder impactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey
AT balıkismail impactofanationwideantibioticrestrictionprogramonantibioticusageandresistanceagainstnosocomialpathogensinturkey